Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
The takeaway: GLP-1s are just one cost driver the real focus for HR is helping employees manage healthcare spending with the tools available
"This will definitely improve one of the issues with access," Dr
Grieco M, Giorgi A, Gentile MC, dErme M, Morano S, Maras B, et al
PMID: 11035391
Table 1 Efficacy of DPP-4 inhibitors in the clinical phase III programmes with at least 52 weeks duration as add on therapy to metformin compared to sulfonylureas
US$ 23.85
US$ 25.41
US$ 28.90
US$ 28.55
US$ 27.30
US$ 29.47
